Vita Life Sciences Ltd. engages in the formulation, packaging, sale and distribution of vitamins and supplements. The company is headquartered in Sydney, New South Wales. The firm is involved in the formulating, packaging, sales and distributing vitamins and supplements. The Company’s core business is the development and distribution of over the counter (OTC) medicines, as well as complementary and alternative medicines, dietary supplements and health foods under various brand names throughout Australia, Malaysia, Singapore, Thailand, Vietnam, China and Indonesia. The company offers products under the brands, such as Herbs of Gold, VitaHealth and VitaScience. The company offers herbal, mineral, vitamin and superfood products under Herbs of Gold brand. The company offers a range of nutritional products under VitaHealth brand. The Company’s subsidiaries include Tetley Research Pty Limited, Tetley Treadmills Pty Limited, Tetley Manufacturing Pty Limited, Vimed Bio Sciences Pty Limited, Allrad No 19 Pty Limited, Lovin Pharma International Limited, Herbs of Gold Pty Limited and Vita Institute of Health Pty Ltd.
Vita Life Sciences (ASX: VLS)
- Home
- Vita Life Sciences (ASX: VLS)
Here are the latest articles on Vita Life Sciences (ASX: VLS)
Vita Life Sciences reports sales growth of $4m as it launches in Vietnam
June 14, 2024
Pharmaceutical and healthcare company Vita Life Sciences (ASX: VLS) has forecasted a positive growth trajectory for the first half of CY24. Besides expecting sales growth, it is also expecting returns from its recent product launch in Vietnam. The Company expects sales to rise to between $39 million and $40 million, up from $34.7 million in
Recent Articles
